Moving forward on tumor pathology research reporting: a guide for pathologists from the WHO Classification of Tumors EVI MAP Group.

Journal

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605

Informations de publication

Date de publication:
17 May 2024
Historique:
received: 27 02 2024
revised: 30 04 2024
accepted: 04 05 2024
medline: 20 5 2024
pubmed: 20 5 2024
entrez: 19 5 2024
Statut: aheadofprint

Résumé

Evidence-based medicine (EBM) can be unfamiliar territory for those working in tumor pathology research and there is a great deal of uncertainty about how to undertake an EBM approach to planning and reporting histopathology-based studies. In this article, endorsed by the WHO International Agency for Research on Cancer's (IARC) International Collaboration for Cancer Classification and Research (IC

Identifiants

DOI: 10.1016/j.modpat.2024.100515 PMID: 38763419
pubmed: 38763419
pii: S0893-3952(24)00095-4
doi: 10.1016/j.modpat.2024.100515
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100515

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Richard Colling (R)

Nuffield Department of Surgical Sciences, University of Oxford, Level 4, John Radcliffe Hospital, Oxford, UK OX3 9DU; Department of Cellular Pathology, Oxford University Hospitals NHS FT, Oxford UK. Electronic address: richard.colling@nds.ox.ac.uk.

Iciar Indave (I)

International Agency for Research on Cancer (IARC), World Health Organization, 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, France.

Javier Del Aguilla (J)

International Agency for Research on Cancer (IARC), World Health Organization, 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, France.

Ramon Cierco Jimenez (RC)

International Agency for Research on Cancer (IARC), World Health Organization, 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, France.

Fiona Campbell (F)

Population Health Sciences, Newcastle University, Newcastle Upon Tyne, N1 7RU, UK.

Magdalena Chechlinska (M)

Department of Cancer Biology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (MSCI).

Magdalena Kowalewska (M)

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (MSCI).

Stefan Holdenrieder (S)

Institute of Laboratory Medicine, German Heart Centre Munich, Munich, Germany (DHM).

Inga Trulson (I)

Institute of Laboratory Medicine, German Heart Centre Munich, Munich, Germany (DHM).

Karolina Worf (K)

Institute of Laboratory Medicine, German Heart Centre Munich, Munich, Germany (DHM).

Marina Pollán (M)

National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain (ISC III); Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Elena Plans-Beriso (E)

National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain (ISC III).

Beatriz Pérez-Gómez (B)

National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain (ISC III); Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Oana Craciun (O)

National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain (ISC III).

Ester García-Ovejero (E)

National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain (ISC III).

Irmina Maria Michalek (IM)

Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (MSCI).

Kateryna Maslova (K)

Department of Cancer Biology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (MSCI).

Grzegorz Rymkiewicz (G)

Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (MSCI).

Joanna Didkowska (J)

Polish National Cancer Registry, Department of Epidemiology and Cancer Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (MSCI).

Puay Hoon Tan (PH)

Luma Medical Centre, Singapore.

Nur Diyana Bte Md Nasir (N)

Luma Medical Centre, Singapore.

Nickolas Myles (N)

International Agency for Research on Cancer (IARC), World Health Organization, 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, France.

Christine Giesen (C)

International Agency for Research on Cancer (IARC), World Health Organization, 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, France.

Gabrielle Goldman-Lévy (G)

International Agency for Research on Cancer (IARC), World Health Organization, 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, France.

Dilani Lokuhetty (D)

International Agency for Research on Cancer (IARC), World Health Organization, 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, France.

Ian A Cree (IA)

International Agency for Research on Cancer (IARC), World Health Organization, 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, France.

Classifications MeSH